Dose-escalation, Repeated and Single Oral Dosing Study

NCT02419820 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
104
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor Decision

Conditions

Interventions

Sponsor

IlDong Pharmaceutical Co Ltd

Collaborators